Reconsidering the usefulness of using long-acting injectable buprenorphine as a tapering tool: a case report of delayed withdrawal months after last dose - Top-Institutions - MDSpire

Reconsidering the usefulness of using long-acting injectable buprenorphine as a tapering tool: a case report of delayed withdrawal months after last dose

  • By

  • Kareem Woods

  • Sophia Graham

  • Steven Dobscha

  • Christopher Blazes

  • July 6, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    University of Kentucky, Center on Drug and Alcohol Research
    University of Kentucky, Center on Drug and Alcohol Research

    Lexington, Kentucky

    Key Differentiators

    • Addiction Medicine

  • #2

    Columbia University Irving Medical Center/New York State Psychiatric Institute
    Columbia University Irving Medical Center/New York State Psychiatric Institute

    New York, New York

    Key Differentiators

    • Addiction Medicine

  • #3

    National Institute on Drug Abuse
    National Institute on Drug Abuse

    Bethesda, Maryland

    Key Differentiators

    • Addiction Medicine

Original Source(s)

Reconsidering the usefulness of using long-acting injectable buprenorphine as a tapering tool: a case report of delayed withdrawal months after last dose

  • by Kareem Woods, Sophia Graham, Steven Dobscha, Christopher Blazes

  • July 6, 2026

Related Content

Mental health consequences of contemporary cannabis use in Europe: potency, patterns of use, and health system context

Metabolomic ageing across mental and behavioural disorders

Are Republicans turning against medications for treating opioid addiction?